Option Care Health (NASDAQ:OPCH) Issues Quarterly Earnings Results, Beats Estimates By $0.02 EPS

Option Care Health (NASDAQ:OPCH) announced its quarterly earnings data on Wednesday. The company reported $0.35 EPS for the quarter, beating analysts’ consensus estimates of $0.33 by $0.02, Zacks reports. Option Care Health had a net margin of 4.37% and a return on equity of 15.30%.

Option Care Health Price Performance

Shares of OPCH stock traded up $0.54 during trading hours on Wednesday, hitting $33.17. The company’s stock had a trading volume of 863,104 shares, compared to its average volume of 1,715,145. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The business has a fifty day moving average of $28.07 and a 200-day moving average of $28.00. Option Care Health has a twelve month low of $21.39 and a twelve month high of $34.17. The stock has a market cap of $5.65 billion, a price-to-earnings ratio of 27.97, a P/E/G ratio of 2.30 and a beta of 1.35.

Analysts Set New Price Targets

OPCH has been the subject of a number of analyst reports. Jefferies Financial Group raised Option Care Health from a “hold” rating to a “buy” rating and increased their target price for the stock from $26.00 to $35.00 in a research note on Thursday, January 23rd. The Goldman Sachs Group cut Option Care Health from a “buy” rating to a “neutral” rating and cut their price objective for the stock from $38.00 to $27.00 in a research report on Monday, November 4th. Bank of America upgraded shares of Option Care Health from a “neutral” rating to a “buy” rating and boosted their target price for the stock from $26.00 to $33.00 in a research report on Monday, January 13th. JMP Securities reiterated a “market outperform” rating and issued a $30.00 price target (down previously from $31.00) on shares of Option Care Health in a report on Friday, January 10th. Finally, UBS Group initiated coverage on shares of Option Care Health in a research note on Thursday, December 5th. They issued a “neutral” rating and a $26.00 price objective for the company. Two equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat, Option Care Health presently has a consensus rating of “Moderate Buy” and a consensus price target of $32.25.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.